Cite
HARVARD Citation
Bettner, W. et al. (n.d.). Developing Precision Medicine in IBD: Peripheral Blood Eosinophilia Identifies Individuals With Worse Outcomes Following Initiation of Anti‐TNF Biologic Agents. American journal of gastroenterology. p. . [Online].